Profile
Sophie Binay is currently the General Manager & Chief Scientific Officer at Acticor Biotech SAS. She previously worked as the Director-Nonclinical Research & Development at Minka Therapeutics SA, the VP-Research & Early Clinical Development at PEP-Therapy SAS, and the Head-Translational Programs at Gustave Roussy Institute.
Sophie Binay active positions
| Companies | Position | Start |
|---|---|---|
| ACTICOR BIOTECH | Chief Tech/Sci/R&D Officer | 2021-06-14 |
Former positions of Sophie Binay
| Companies | Position | End |
|---|---|---|
Minka Therapeutics SA
Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops a portfolio of therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS | Chief Tech/Sci/R&D Officer | - |
Gustave Roussy Institute | Corporate Officer/Principal | - |
PEP-Therapy SAS
PEP-Therapy SAS BiotechnologyHealth Technology biotechnology development and research. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Minka Therapeutics SA
Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops a portfolio of therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS | Health Technology |
PEP-Therapy SAS
PEP-Therapy SAS BiotechnologyHealth Technology biotechnology development and research. | Health Technology |
Acticor Biotech SAS
Acticor Biotech SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Commercial Services |
Gustave Roussy Institute |
- Stock Market
- Insiders
- Sophie Binay
















